ACCENTIS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ACCENTIS Trademark

Serial Number: 79377769

ACCENTIS is a trademark filed by EUROIMMUN Medizinische Labordiagnostika AG on July 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

EUROIMMUN Medizinische Labordiagnostika AG

Seekamp 31
Lübeck 23560 , DE

Entity Type: 25

Trademark Details

Filing Date

July 27, 2023

Registration Date

Not Registered

Goods & Services

Diagnostic preparations for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposes, in particular recombinantly or synthetically produced antigens, lysates of microorganisms, preparations for conducting serological tests, biochemical preparations for conducting confirmatory tests; diagnostic preparations for medical and veterinary purposes, in particular immobilised proteins on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; diagnostic preparations for medical and veterinary purposes, in particular immobilised proteins on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; diagnostic preparations for medical and veterinary purposes, in particular immobilised peptides or immobilised polypeptides on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; diagnostic preparations for medical and veterinary purposes, in particular immobilised peptides or immobilised polypeptides on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; immunoserological test kits, comprising reagents that are matched to one another for conducting immunoserological tests for medical and veterinary purposes for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising reagents that are matched to one another for conducting diagnostic tests for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised proteins on a carrier, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised proteins on a carrier material, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised peptides or immobilised polypeptides on a carrier, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised peptides or immobilised polypeptides on a carrier material, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising surface modified or surface activated microbeads or nanobeads enabling the coupling of proteins, polypeptides and peptides for use in disease, disorder, medical or veterinary condition testing and genetic testing; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnostic purposes, in particular immobilised proteins on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; reagents for medical and veterinary diagnostic purposes, in particular immobilised proteins on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; reagents for medical and veterinary diagnostic purposes, in particular immobilised peptides or immobilised polypeptides on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; reagents for medical and veterinary diagnostic purposes, in particular immobilised peptides or immobilised polypeptides on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; all aforementioned goods being not for or in connection with ophthalmic and ophthalmological pharmaceutical products.

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 21, 2026 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 21, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 20, 2025 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 15, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 26, 2025 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 10, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 21, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 21, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 6, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 5, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 9, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 31, 2023 REPR